Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSP-6952 (minesapride) in patients with irritable bowel syndrome with constipation: randomized, placebo-controlled early phase 2 trial
jRCT2080221995Phase 2Completed
- Sponsor
- Sumitomo Pharma
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Minesapride with Placebo (2 arms). Started Dec 2012; status: completed.
02
Drugs
minesapride
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on jRCT2080221995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221995.